RivaroxabanA Review of its Use for the Prophylaxis of Venous Thromboembolism after Total Hip or Knee Replacement Surgery

被引：0
作者：
Sean T. Duggan
机构：
[1] Adis,
来源：
American Journal of Cardiovascular Drugs | 2012年 / 12卷
关键词：
Enoxaparin; Rivaroxaban; Total Knee Replacement; Enoxaparin Sodium; Prothrombin Complex Concentrate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Rivaroxaban (Xarelto®), an oral oxazolidinone-based anticoagulant, is a potent, selective, direct inhibitor of factor Xa that is used in the prevention of venous thromboembolism (VTE) in adult patients after total hip replacement (THR) or total knee replacement (TKR) surgery.
引用
收藏
页码：57 / 72
页数：15
相关论文
共 163 条
[1]  
Hyers T.M.(2003)Management of venous thromboembolism: past, present, and future Arch Intern Med 163 759-68
[2]  
Geerts W.H.(2008)Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition) Chest 133 381-453S
[3]  
Bergqvist D.(2011)Prevalence of clinical venous thromboembolism in the USA: current trends and future projections Am J Hematol 86 217-20
[4]  
Pineo G.F.(2004)Orthopaedic surgery as a model for drug development in thrombosis Drugs 64 17-25
[5]  
Deitelzweig S.B.(1996)The long-term clinical course of acute deep venous thrombosis Ann Intern Med 125 1-7
[6]  
Johnson B.H.(2007)Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations J Manage Care Pharm 13 475-86
[7]  
Lin J.(2009)Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors in development Clin Pharmacokinet 48 1-22
[8]  
Dahl O.E.(2006)Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery Drugs 66 1411-29
[9]  
Prandoni P.(2005)In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939: an oral, direct factor Xa inhibitor J Thromb Haemost 3 514-21
[10]  
Lensing A.W.(2007)Preclinical and clinical characteristics of rivaroxaban: a novel, oral, direct factor Xa inhibitor Semin Thromb Hemost 33 515-23
12345678910